Biocept Stock News

Healthcare > Medical - Diagnostics & Research

Buy BIOC

*Your capital is at risk

$0.435

+0 (+0%)

At Close: Jan 23, 2024

30 Stocks Moving in Monday's Pre-Market Session

10:56am, Monday, 13'th Apr 2020

Gainers Biocept, Inc. (NASDAQ: BIOC) shares rose 68.3% to $0.5997 in pre-market trading. Biocept disclosed that it has verified a COVID-19 molecular diagnostic test. U.S. Well...

Biocept shares are trading higher after the company said it has a coronavirus test and will begin accepting physician orders this week.

12:00am, Monday, 13'th Apr 2020

Biocept to Begin COVID-19 Testing

11:17pm, Thursday, 09'th Apr 2020

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed w

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by